ISSCR News


The ISSCR Opens Registration and Abstract Submission for 2024 Annual Meeting in Hamburg, Germany
Press Release Kym Kilbourne Press Release Kym Kilbourne

The ISSCR Opens Registration and Abstract Submission for 2024 Annual Meeting in Hamburg, Germany

ISSCR 2024 is the most clinically focused annual meeting in the society’s 20+ years. Fueled by basic research and unparalleled development of new technologies, the field is seeing more stem cell-based clinical trials than at any time in history. The meeting serves as an incubator, a catalyst for new advances at each point in the research continuum.

Read More
ISSCR Launches Website to Inform Patients and the Public About Stem Cells
Press Release Kym Kilbourne Press Release Kym Kilbourne

ISSCR Launches Website to Inform Patients and the Public About Stem Cells

“The ISSCR has a long history of sharing scientifically validated information about the potential of stem cell research and clinical advances with the public,” said Amander T. Clark, ISSCR President. “Our reimagined website, AboutStemCells.org, gives us an important avenue to educate the public about the importance of our work, combat misinformation, and raise awareness for the dangers of using unproven and unapproved stem cell-based treatments.”

Read More
Message from the President
Message from the President Kym Kilbourne Message from the President Kym Kilbourne

Message from the President

I have watched the Israel-Hamas war escalate this week with profound sadness and deep concern for those in our community impacted by the violence, devastation, and loss of life. This is an unjust and deeply troubling event on top of many recent attacks against innocent lives around the world. We stand in solidarity with our colleagues and their families; we condemn these acts of terror.

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .